risedronate sodium (Actonel)

DRUG2 trials

Sponsors

Warner Chilcott, Sanofi

Conditions

Osteogenesis ImperfectaOsteoporosis, Postmenopausal

Phase 3

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

CompletedNCT00106028

Warner ChilcottOsteogenesis Imperfecta

Start: 2004-11-30End: 2010-03-31Updated: 2013-04-22

Phase 4

POWER Point of Care Effect on Satisfaction of Treatment

CompletedNCT00549068

SanofiOsteoporosis, Postmenopausal

Start: 2003-02-28End: 2004-11-30Updated: 2009-12-07

Related Papers

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.

2013-08-06126 citations